Dont hold your breath. They havent even bothered reporting on the 'failed' melanoma trials. Cant even be prompt with updating share transfers. Discloure has never been their strong point. Hiding behind unlisted, sure has been though
Week 45 Wrap: Combat sports usher in Trump 2.0 – or is it male insecurity?; RBA boring; Propane suggests China alive
MKT The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint
